Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Urinary incontinence in neurological disease: assessment and management

Clinical guideline
Reference number: CG148
Published: 08 August 2012
Last updated: 02 October 2023

History

Stakeholder list updated

Stakeholder list (PDF 135 KB)

Published:

04 February 2019

Surveillance consultation

Surveillance consultation
Comments form (MSWord 27 KB)

Published:

16 November 2018
Surveillance review proposal (PDF 439 KB)

Published:

16 November 2018

Review documents

Static list review decision (PDF 1.38 MB)

Published:

17 February 2014

Background information

Press release information

Incontinence in neurological disease: guideline consultation

Incontinence in neurological disease: guideline consultation information
Incontinence in neurological disease: full guideline (PDF 4.88 MB)

Published:

08 March 2012
Incontinence in neurological disease: appendices (PDF 7.13 MB)

Published:

08 March 2012
Incontinence in neurological disease: NICE guideline (PDF 273 KB)

Published:

08 March 2012

Incontinence in neurological disease: remit

Incontinence in neurological disease: remit (PDF 17 KB)

Published:

11 November 2009

Incontinence in neurological disease: scoping workshop, consultation and final scope

Incontinence in neurological disease: scoping workshop, consultation and final scope
Incontinence in neurological disease: scope (PDF 82 KB)

Published:

28 September 2010
Incontinence in neurological disease: scope comments table (PDF 211 KB)

Published:

28 September 2010
Incontinence in neurological disease: scoping workshop notes (PDF 46 KB)

Published:

28 September 2010
Incontinence in neurological disease: GDG members list (PDF 9.6 KB)

Published:

28 September 2010
Incontinence in neurological disease: equality impact assessment form (PDF 164 KB)

Published:

17 February 2012
Incontinence in neurological disease: draft scope consultation information
Incontinence in neurological disease: draft scope (PDF 49 KB)

Published:

02 July 2010
Incontinence in neurological disease: draft scope comments form (MSWord 44 KB)

Published:

02 July 2010
Incontinence in neurological disease: stakeholder list (PDF 75 KB)

Published:

16 May 2011

Incontinence in neurological disease: guideline development and consultation

Incontinence in neurological disease: guideline development and consultation
Incontinence in Neurological Disease: Equality Impact Assessment form (PDF 119 KB)

Published:

23 September 2013
Incontinence in neurological disease: consultation comments table (PDF 397 KB)

Published:

08 August 2012
Incontinence in neurological disease: GDG minutes
Incontinence in neurological disease: GDG minutes - 9 December 2011 (PDF 59 KB)

Published:

26 July 2012
Incontinence in neurological disease: : GDG minutes - 11 November 2011 (PDF 96 KB)

Published:

16 February 2012
Incontinence in neurological disease: GDG minutes - 14 October 2011 (PDF 56 KB)

Published:

02 December 2011
Incontinence in neurological disease: GDG minutes - 9 September 2011 (PDF 76 KB)

Published:

02 December 2011
Incontinence in neurological disease: GDG minutes - 29 July 2011 (PDF 59 KB)

Published:

23 September 2011
Incontinence in neurological disease: GDG minutes - 24 June 2011 (PDF 43 KB)

Published:

10 August 2011
Incontinence in neurological disease: GDG minutes - 20 May 2011 (PDF 138 KB)

Published:

10 August 2011
Incontinence in neurological disease: GDG minutes - 13 April 2011 (PDF 42 KB)

Published:

10 August 2011
Incontinence in neurological disease: GDG minutes - 11 March 2011 (PDF 54 KB)

Published:

10 August 2011
Incontinence in neurological disease: GDG minutes - 4 February 2011 (PDF 55 KB)

Published:

10 August 2011
Incontinence in neurological disease: GDG minutes - 15 December 2010 (PDF 58 KB)

Published:

10 August 2011
Incontinence in neurological disease: GDG minutes - 5 November 2010 (PDF 56 KB)

Published:

17 February 2011

National Clinical Guideline Centre for Acute and Chronic Conditions

National Clinical Guideline Centre for Acute and Chronic Conditions information